| Industrial Conglomerates Industry | Industrials Sector | Marc Arthur Ronchetti CEO | XSTU Exchange | GB0004052071 ISIN |
| GB Country | 8,000 Employees | 9 Jul 2026 Last Dividend | 11 Aug 1997 Last Split | - IPO Date |
Halma plc is a diversified technology company primarily operating in the safety, health, and environmental markets. With its foundation dating back to 1894, it has grown to deliver a wide array of technology solutions globally. The company navigates through its mission with a clear focus on three core segments: Safety, Environmental & Analysis, and Medical. Each segment caters to a specific set of needs, from protecting people and assets to ensuring environmental sustainability and advancing health care. Headquartered in Amersham, the United Kingdom, Halma demonstrates a commitment to innovation, life protection, and improving the quality of life through its numerous subsidiaries spread across different markets.
This segment contributes to a safer world through an array of technologies, including fire detection systems, specialist fire suppression, elevator safety, and explosion protection. Notable products include security sensors, people and vehicle flow technologies, and specialized interlocks for controlling critical processes safely. Markets served include fire suppression, elevator safety, industrial access control, and more, emphasizing Halma’s commitment to protecting assets and ensuring industrial safety.
Halma's focus on environmental sustainability is evident in its Environmental & Analysis segment, offering products such as optical, optoelectronic, and spectral imaging systems. Additionally, it provides technologies for monitoring water, air, and gases alongside instruments for detecting hazardous gases and analyzing air quality. Systems for water analysis and treatment also play a crucial role, serving essential markets like optical analysis, environmental monitoring, and gas detection, thereby supporting global efforts in environmental conservation and safety.
This segment is dedicated to advancing healthcare through a variety of technologies and solutions. It includes critical fluidic components for medical diagnostics, laboratory devices, and systems that assist in patient health understanding. Halma also offers technologies to facilitate in-vitro diagnostic systems, life-science research, and therapeutic solutions across clinical specialties. Serving the life sciences, health assessment, and therapeutic solutions market, this segment showcases Halma’s dedication to enhancing healthcare outcomes and enabling discoveries in medicine.